Merck Financial Statements From 2010 to 2024

Merck Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Other Current Liabilities 4.3 B 5 B 3.6 B Slightly volatile Total Current Liabilities 27.1 B 25.7 B 23.4 B Slightly volatile Other Liabilities 9.1 B 8.2 B 11.8 B Slightly volatile Retained Earnings 57.8 B 53.9 B 49.3 B Slightly volatile Accounts Payable 3.9 B 3.9 B 4.5 B Pretty Stable Other Assets 9 B 8.5 B 6.5 B Slightly volatile Net Receivables 10.1 B 10.3 B 8 B Slightly volatile Inventory 6.5 B 6.4 B 6 B Slightly volatile Other Current Assets 6.7 B 8.4 B 4.9 B Slightly volatile Total Current Assets 33.7 B 32.2 B 29 B Slightly volatile Common Stock 1.4 B 1.6 B 1.8 B Slightly volatile Property Plant Equipment 21.6 B 26.2 B 18.1 B Slightly volatile Total Assets 113.6 B 106.7 B 96.2 B Slightly volatile Total Stockholder Equity 40.4 B 37.6 B 29.4 B Slightly volatile Property Plant And Equipment Net 22.2 B 23.1 B 18.2 B Slightly volatile Net Debt 26.1 B 28.2 B 23.9 B Pretty Stable Cash 9.8 B 6.8 B 8.4 B Slightly volatile Non Current Assets Total 79 B 74.5 B 67 B Slightly volatile Non Currrent Assets Other 9.2 B 12 B 12.4 B Slightly volatile Long Term Debt 32.6 B 33.7 B 27 B Slightly volatile Good Will 22.7 B 21.2 B 19.6 B Slightly volatile Common Stock Shares Outstanding 2.8 B 2.5 B 2.5 B Slightly volatile Non Current Liabilities Total 45.3 B 43.3 B 39.9 B Slightly volatile Total Liabilities 73.1 B 69 B 66.7 B Slightly volatile Net Invested Capital 76.4 B 72.6 B 61.7 B Slightly volatile Long Term Investments 484.4 M 252 M 717.1 M Slightly volatile Property Plant And Equipment Gross 42.2 B 41.3 B 36.5 B Slightly volatile Short and Long Term Debt 2.4 B 1.4 B 5.3 B Slightly volatile Capital Stock 1.4 B 1.6 B 1.8 B Slightly volatile Non Current Liabilities Other 7.8 B 8.8 B 11.3 B Slightly volatile Net Working Capital 6.8 B 6.5 B 2.4 B Slightly volatile Intangible Assets 20.7 B 18 B 15.8 B Slightly volatile
Merck Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Discontinued Operations 601.9 M 633.6 M 3.1 B Slightly volatile EBIT 11.8 B 16 B 11.3 B Slightly volatile Net Income Applicable To Common Shares 11 B 15 B 10.5 B Slightly volatile Income Tax Expense 1.2 B 1.4 B 1.5 B Slightly volatile Tax Provision 1.7 B 1.5 B 1.4 B Slightly volatile Interest Income 383.2 M 365 M 106 M Slightly volatile Interest Expense 1 B 1.1 B 872.3 M Slightly volatile Selling General Administrative 10.8 B 10.5 B 9.3 B Slightly volatile Total Revenue 57.6 B 60.1 B 45.5 B Slightly volatile Gross Profit 40.9 B 44 B 31.3 B Slightly volatile Operating Income 2.8 B 3 B 6.6 B Pretty Stable Net Income From Continuing Ops 358.1 M 377 M 5.2 B Pretty Stable Research Development 19.2 B 30.5 B 14.9 B Slightly volatile Cost Of Revenue 16.7 B 16.1 B 14.2 B Slightly volatile Total Operating Expenses 46.7 B 57.2 B 38.4 B Slightly volatile Reconciled Depreciation 4 B 3.9 B 3.6 B Slightly volatile Income Before Tax 1.8 B 1.9 B 6.6 B Pretty Stable Net Income 346.8 M 365 M 7.1 B Pretty Stable
Merck Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Net Borrowings 2.9 B 1.9 B 1.7 B Slightly volatile Depreciation 3.8 B 3.9 B 3.2 B Slightly volatile Dividends Paid 7.3 B 7.4 B 6.1 B Slightly volatile Capital Expenditures 4.5 B 3.9 B 3.7 B Slightly volatile Total Cash From Operating Activities 15.4 B 13 B 13.7 B Slightly volatile Net Income 346.8 M 365 M 8.9 B Slightly volatile End Period Cash Flow 7.3 B 6.9 B 9.5 B Slightly volatile Change To Netincome 2.4 B 1.6 B 2.5 B Pretty Stable Change To Liabilities 408.5 M 364.5 M 446.5 M Very volatile Stock Based Compensation 579.1 M 645 M 473 M Slightly volatile Free Cash Flow 10.8 B 9.1 B 7.2 B Slightly volatile Begin Period Cash Flow 10.7 B 12.8 B 9.9 B Very volatile Other Non Cash Items 12.4 B 11.8 B 4.8 B Slightly volatile

Merck Fundamental Market Drivers

About Merck Financial Statements

When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:

How To Invest In Merck Details

Is Merck Stock a good investment? Details

What is Merck's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Intrinsic Valuation Details

Financial Analysis Details

Buy or Sell Advice Details

Technical Analysis Details

Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.